Skip to Main Content

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Conditions

Diseases of the Nervous System

Phase III

What is the purpose of this trial?

The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to placebo in participants with generalized myasthenia gravis (gMG).

  • Trial with
    Janssen Research & Development, LLC
  • Start Date
    05/16/2022
  • End Date
    02/21/2024

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    06/16/2022
  • Study HIC
    #2000031341